Cargando…
Cancer diagnosis is one quarter lower than the expected cancer incidence in the first year of COVID‐19 pandemic in Germany: A retrospective register‐based cohort study
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257987/ https://www.ncbi.nlm.nih.gov/pubmed/35633279 http://dx.doi.org/10.1002/cac2.12314 |
_version_ | 1784741442500952064 |
---|---|
author | Diers, Johannes Acar, Laura Wagner, Johanna C. Baum, Philip Hankir, Mohammed Flemming, Sven Kastner, Carolin Germer, Christoph‐Thomas L'hoest2, Helmut Marschall, Ursula Lock, Johan Friso Wiegering, Armin |
author_facet | Diers, Johannes Acar, Laura Wagner, Johanna C. Baum, Philip Hankir, Mohammed Flemming, Sven Kastner, Carolin Germer, Christoph‐Thomas L'hoest2, Helmut Marschall, Ursula Lock, Johan Friso Wiegering, Armin |
author_sort | Diers, Johannes |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9257987 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92579872022-07-08 Cancer diagnosis is one quarter lower than the expected cancer incidence in the first year of COVID‐19 pandemic in Germany: A retrospective register‐based cohort study Diers, Johannes Acar, Laura Wagner, Johanna C. Baum, Philip Hankir, Mohammed Flemming, Sven Kastner, Carolin Germer, Christoph‐Thomas L'hoest2, Helmut Marschall, Ursula Lock, Johan Friso Wiegering, Armin Cancer Commun (Lond) Letters to the Editor John Wiley and Sons Inc. 2022-05-28 /pmc/articles/PMC9257987/ /pubmed/35633279 http://dx.doi.org/10.1002/cac2.12314 Text en © 2022 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Letters to the Editor Diers, Johannes Acar, Laura Wagner, Johanna C. Baum, Philip Hankir, Mohammed Flemming, Sven Kastner, Carolin Germer, Christoph‐Thomas L'hoest2, Helmut Marschall, Ursula Lock, Johan Friso Wiegering, Armin Cancer diagnosis is one quarter lower than the expected cancer incidence in the first year of COVID‐19 pandemic in Germany: A retrospective register‐based cohort study |
title | Cancer diagnosis is one quarter lower than the expected cancer incidence in the first year of COVID‐19 pandemic in Germany: A retrospective register‐based cohort study |
title_full | Cancer diagnosis is one quarter lower than the expected cancer incidence in the first year of COVID‐19 pandemic in Germany: A retrospective register‐based cohort study |
title_fullStr | Cancer diagnosis is one quarter lower than the expected cancer incidence in the first year of COVID‐19 pandemic in Germany: A retrospective register‐based cohort study |
title_full_unstemmed | Cancer diagnosis is one quarter lower than the expected cancer incidence in the first year of COVID‐19 pandemic in Germany: A retrospective register‐based cohort study |
title_short | Cancer diagnosis is one quarter lower than the expected cancer incidence in the first year of COVID‐19 pandemic in Germany: A retrospective register‐based cohort study |
title_sort | cancer diagnosis is one quarter lower than the expected cancer incidence in the first year of covid‐19 pandemic in germany: a retrospective register‐based cohort study |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257987/ https://www.ncbi.nlm.nih.gov/pubmed/35633279 http://dx.doi.org/10.1002/cac2.12314 |
work_keys_str_mv | AT diersjohannes cancerdiagnosisisonequarterlowerthantheexpectedcancerincidenceinthefirstyearofcovid19pandemicingermanyaretrospectiveregisterbasedcohortstudy AT acarlaura cancerdiagnosisisonequarterlowerthantheexpectedcancerincidenceinthefirstyearofcovid19pandemicingermanyaretrospectiveregisterbasedcohortstudy AT wagnerjohannac cancerdiagnosisisonequarterlowerthantheexpectedcancerincidenceinthefirstyearofcovid19pandemicingermanyaretrospectiveregisterbasedcohortstudy AT baumphilip cancerdiagnosisisonequarterlowerthantheexpectedcancerincidenceinthefirstyearofcovid19pandemicingermanyaretrospectiveregisterbasedcohortstudy AT hankirmohammed cancerdiagnosisisonequarterlowerthantheexpectedcancerincidenceinthefirstyearofcovid19pandemicingermanyaretrospectiveregisterbasedcohortstudy AT flemmingsven cancerdiagnosisisonequarterlowerthantheexpectedcancerincidenceinthefirstyearofcovid19pandemicingermanyaretrospectiveregisterbasedcohortstudy AT kastnercarolin cancerdiagnosisisonequarterlowerthantheexpectedcancerincidenceinthefirstyearofcovid19pandemicingermanyaretrospectiveregisterbasedcohortstudy AT germerchristophthomas cancerdiagnosisisonequarterlowerthantheexpectedcancerincidenceinthefirstyearofcovid19pandemicingermanyaretrospectiveregisterbasedcohortstudy AT lhoest2helmut cancerdiagnosisisonequarterlowerthantheexpectedcancerincidenceinthefirstyearofcovid19pandemicingermanyaretrospectiveregisterbasedcohortstudy AT marschallursula cancerdiagnosisisonequarterlowerthantheexpectedcancerincidenceinthefirstyearofcovid19pandemicingermanyaretrospectiveregisterbasedcohortstudy AT lockjohanfriso cancerdiagnosisisonequarterlowerthantheexpectedcancerincidenceinthefirstyearofcovid19pandemicingermanyaretrospectiveregisterbasedcohortstudy AT wiegeringarmin cancerdiagnosisisonequarterlowerthantheexpectedcancerincidenceinthefirstyearofcovid19pandemicingermanyaretrospectiveregisterbasedcohortstudy |